People

• Academy of Finland Centre of Excellence on Body on Chip Technology
• Hybrid Enhanced Regenerative Medicine Systems

 My passion is to seek for new knowledge and methods for future personalized 

medicine. We are interested in understanding and assessing mechanisms of

 biophysics by developing in-vitro, 3D bioimaging and computational modelling tools for assessing the cellular functions.

We study biophysics,

 especially electrophysiology and biomechanics using and developing 

microscopy, bioimpedance, patch clamp, and multichannel electrode arrays

 (MEAs). 

We develop new methods for 3D bioimaging

 and image-based assessment of cellular and tissue functions developing 

multimodal and hybrid imaging systems with optical, electric and X-ray 

3D imaging methodsWe develop computational models to decipher biophysics integrating in-silico and in-vitro human induced stem cell personalized and drug screening platforms. 

International Federation on Medical and Biological Engineering (www.ifmbe.org)

 Member of the Administrative Council 2018 - 

European Alliance for Medical and Biological Engineering & Sciences (www.eambes.org) :

 2019- Member of the Council (councillor of Fellows)

2017-2019 Past-President 

 2015-2017 President 

 2014-2015 President-Elect 

 2011-2014 Member of the Council (Chair of the Public affairs working group) 

 2008-2011 Member of general council 

EAMBES fellows division

Chair of Fellows 2017-2019 

Past Chair 2019-  

Finnish Society for Medical Physics and Medical Engineering (Lääketieteellisen fysiikan

ja tekniikan yhdistys ry.) (www.lfty.fi) :

2001-2004 Chairman 

1998-1999 Treasurer 

1992-1998 Secretary 

International Society for Bioelectromagnetism (www.isbem.org):

2007-2014 Secretary  

1995-2002 Council member 

Member of the board: Institute of biotechnology (IBT), University of Tampere, 2011 -2013

BioMediTech, University of Tampere, 2011 -2013 Member of the board:  

Institute of Medical Sciences and Medical Technolgies A joint Institute of Tampere University and Tampere University of Technology, Tampere Finland (www.biomeditech.fi)

2011– 2014 Member of the steering board,  

See google scholar

Terho Lehtimäki has over 1200 publications from the field including articles in all world top journals, e.g., Science, Lancet, Nature, Nature Genetics, Cell, NEJM, JAMA and Circulation. Hirch Index 142. With over 120.000 ciations.

Find here the list of publications. 

• Google Scholar
• Scholar Chart

1. Methylation status of nc886 epiallele reflects periconceptional conditions and is associated with glucose metabolism through nc886 RNAs. Marttila S, Viiri LE, Mishra PP, Kühnel B, Matias-Garcia PR, Lyytikäinen LP, Ceder T, Mononen N, Rathmann W, Winkelmann J, Peters A, Kähönen M, Hutri-Kähönen N, Juonala M, Aalto-Setälä K, Raitakari O, Lehtimäki T, Waldenberger M, Raitoharju E. Clin Epigenetics. 2021 Jul 22;13(1):143. doi: 10.1186/s13148-021-01132-3. IF=6.551

2. Human Prostate Tissue MicroRNAs and Their Predicted Target Pathways Linked to Prostate Cancer Risk Factors. Enwald M, Lehtimäki T, Mishra PP, Mononen N, Murtola TJ, Raitoharju E. Cancers (Basel). 2021 Jul 15;13(14):3537. doi: 10.3390/cancers13143537. IF=6.639

3. Adulthood blood levels of hsa-miR-29b-3p associate with preterm birth and adult metabolic and cognitive health. Marttila S, Rovio S, Mishra PP, Seppälä I, Lyytikäinen LP, Juonala M, Waldenberger M, Oksala N, Ala-Korpela M, Harville E, Hutri-Kähönen N, Kähönen M, Raitakari O, Lehtimäki T, Raitoharju E. Sci Rep. 2021 Apr 28;11(1):9203. doi: 10.1038/s41598-021-88465-4. IF= 4.379

4. Whole blood microRNA levels associate with glycemic status and correlate with target mRNAs in pathways important to type 2 diabetes. Mononen N, Lyytikäinen LP, Seppälä I, Mishra PP, Juonala M, Waldenberger M, Klopp N, Illig T, Leiviskä J, Loo BM, Laaksonen R, Oksala N, Kähönen M, Hutri-Kähönen N, Raitakari O, Lehtimäki T, Raitoharju E. Sci Rep. 2019 Jun 20;9(1):8887. doi: 10.1038/s41598-019-43793-4. IF = 4.259 

5. Blood hsa-miR-122-5p and hsa-miR-885-5p levels associate with fatty liver and related lipoprotein metabolism - The Young Finns Study. Raitoharju E, Seppälä I, Lyytikäinen L-P, Viikari J, Ala-Korpela M, Soininen P , Kangas AJ, Waldenberger M, Klopp N, Illig T, Leiviskä J, Loo B-M, Oksala N, Kähönen M, Hutri-Kähönen N, Laaksonen R, Raitakari O, Lehtimäki T. Sci Rep. 2017 Jan 27;7:41483. doi: 10.1038/srep41483. IF = 4.259 

6. Blood microRNA profile associates with the levels of serum lipids and metabolites associated with glucose metabolism and insulin resistance and pinpoints pathways underlying metabolic syndrome: The cardiovascular risk in Young Finns Study. Raitoharju E, Seppälä I, Oksala N, Lyytikäinen LP, Raitakari O, Viikari J, Ala-Korpela M, Soininen P, Kangas AJ, Waldenberger M, Klopp N, Illig T, Leiviskä J, Loo BM, Hutri-Kähönen N, Kähönen M, Laaksonen R, Lehtimäki T. Mol Cell Endocrinol. 2014 Apr 28;391(1-2):41-49 IF = 3.754 

7. MicroRNAs in the Atheroclerotic Plaque. Raitoharju E, Oksala N, Lehtimäki T. Clin Chem. 2013 May 31. doi: 10.1373/clinchem.2013.204917. IF = 7.292

8. MicroRNA-616 and atherosclerosis--a commentary on the paper by Liu et al. Raitoharju E. Atherosclerosis. 2013 May;228(1):42-3. IF =4.239

9. A comparison of the accuracy of Illumina HumanHT-12 v3 Expression BeadChip and TaqMan qRT-PCR gene expression results in patient samples from the Tampere Vascular Study. Raitoharju E, Seppälä I, Lyytikäinen LP, Levula M, Oksala N, Klopp N, Illig T, Laaksonen R, Kähönen M, Lehtimäki T. Atherosclerosis. 2013 Jan;226(1):149-52. IF = 4.239 

10. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Raitoharju E, Lyytikäinen LP, Levula M, Oksala N, Mennander A, Tarkka M, Klopp N, Illig T, Kähönen M, Karhunen PJ, Laaksonen R, Lehtimäki T. Atherosclerosis. 2011 Nov;219(1):211-7. IF = 4.239

The winner of the Soisalo award in 2020 granted by the Finnish Foundation for Cardiovascular Research. The award is granted for a young prominent Finnish cardiovascular researcher once every two years.

https://pubmed.ncbi.nlm.nih.gov/31422363/

https://pubmed.ncbi.nlm.nih.gov/29092920/

https://pubmed.ncbi.nlm.nih.gov/28613276/

https://pubmed.ncbi.nlm.nih.gov/28416818/

https://pubmed.ncbi.nlm.nih.gov/28146470/

https://pubmed.ncbi.nlm.nih.gov/25908775/

https://pubmed.ncbi.nlm.nih.gov/19687159/